Skip to main content
メニュー
JP

Easy. Precise. Cost-effective.

Vanadis® NIPT system is an automated cell-free DNA testing platform designed to make noninvasive prenatal testing accessible to more women – and more cost-effective for your laboratory.


Products may not be licensed in accordance with the laws in all countries, such as the United States. Please check with your local representative for availability.

Vanadis NIPT System
WORKFLOW

Streamlined workflow from primary tube to final result

Screen for the risk of trisomies 21, 18, 13, as well as fetal sex determination with Vanadis NIPT. By targeting thousands of chromosomal sequences, the Vanadis system can bring high precision non-invasive prenatal testing to your lab, counting an average of 650,000 molecules per chromosome.

vanadis-nipt-system-new-body-1310x271.png

Walkaway automation for greater efficiency

With Vanadis technology, all the critical steps are automated, starting with pipetting steps to reduce manual errors. Plasma volumes are monitored by camera to avoid contamination by the buffy coat, and samples and reagents are barcoded for complete tracking throughout the workflow. Our software guides you through the process, with user-friendly touchscreens, enabling remote workflow management for ease of use. Easy to integrate, our software is designed for LIMS connectivity, reducing manual errors while simplifying data management.

GROUNDBREAKING cfDNA TECHNOLOGY

No PCR, No sequencing

Vanadis is the only NIPT screening platform to enable targeted cfDNA analysis without PCR, instead directly capturing target fragments and labeling them for counting. A proprietary nanofilter plate then captures labeled molecules for imaging, eliminating the need for data-intensive steps such as DNA sequencing, microarrays, and microfluidics.

Benefits for your laboratory

revvity-core-and-SW-thumbnail

Easy to use. Easy to learn

Walkaway automation minimizes hands-on time and allows for quicker test results, available within 2-3 days.

scalable-platform

Scalable platform

Requiring only a single technician to run up to 14 000 samples per year, Vanadis empowers laboratories under ever-increasing workloads.

revvity-software-and-view-thumbnail

High-precision technology

Designed to deliver high-precision measurements to improve the detection and false positive rates while minimizing the no-call rate.

KITS

Proven clinical performance

Clinical studies have demonstrated that the Vanadis NIPT system could improve detection and false positive rates, while minimizing the number of no-calls.

Products comprising the Vanadis NIPT system are CE-marked in vitro diagnostic products in accordance with European directive 98/79/EC.

 

Trisomy 21

Trisomy 18

Trisomy 13

Detection Rate (95% CI)

100%

(80/80)

(95.5%-100%)

91.4%

(32/35)

(76.9%-98.2%)

100%

(10/10)

(69.2%-100%)

False Positive Rate (95% CI)

0.0%

(0/666)

(0.0%-0.6%)

0.2%

(2/1033)

(0.0%-0.7%)

0.1%

(1/1033)

(0.0%-0.5%)

The observed no-call rate: 0.94% (after first pass)


Source: Vanadis kit insert, version 4

SOFTWARE

Leading risk calculation software

open_labLady

LifeCycle™ software

Vanadis™ NIPT system includes System Software and trusted LifeCycle™ software, the complete data management solution for prenatal screening laboratories. With a simple and flexible user interface and a performance monitoring dashboard that enables access from any current Web browser, these software provide the reliability and support laboratories can rely on.

Learn more about LifeCycle™
bg-element-listing-page bg-element-listing-page-mobile
Products & Services
Resource Library
Filters
Expand All|Collapse All
Resource Type
Sort by: Resource Name A-Z
Resource Name A-Z
Resource Name Z-A
1 - 9 of 9 Resources
Literature - Publication Review
Literature - Publication Review
60 second spotlight: prenatal screening for autosomal trisomies

Flyer summary of a study into twin preganacies

Video
Video
Addressing evolving laboratory needs through innovative workflows

Revvity's Symposium presentation from ESHG 2023 (European Society of Human Genetics). A compilation of talks from forward-thinking laboratory leaders, highlighting their innovative methods and services. Designing efficient laboratory processes through a simplified approach, each segment presents a unique situation where laboratories drive optimal outcomes through the creative and streamlined utilization of laboratory workflows. Tapping into their diverse scientific backgrounds, our speakers show how we can all advance laboratory science and challenge the status quo.

Webinar
Webinar
Implications of fetal fraction measurement variability in NIPS

Fredrik Persson was one of the first members to join the Swedish start-up Vanadis Diagnostics to develop a high precision cost-effective accessible solution for Non-Invasive Prenatal Testing (NIPT). With a PhD in Experimental Biophysics, Fredrik joined Revvity in December 2015 as part of the Vanadis acquisition. Fredrik has authored 25+ peer-reviewed publications in books and journals such as e.g. Nature Methods and Nature Genetics.

Video
Video
Laboratory Solutions for Reproductive Health

This video provides an overview of Revvity's reproductive health offerings, designed for laboratories.

Flyer
Flyer
LifeCycle Software (IVD) Flyer

Flyer for LifeCycle software for prenatal risk calculation (pre-eclampsia, NIPT) IVD

Infographic
Infographic
The impact of no-call rate in NIPT

Based on the no-call rate for a particular NIPT, providers may receive more or fewer no-call results on behalf of their patients. These no-call results can have varying effects across all parties. See for yourself - discover how the no-call rate impacts clinical care for patients and providers alike in the following infographic.

Brochure
Brochure
Vanadis NIPT system

Brochure material that highlights the Vanadis NIPT system.

Flyer
Flyer
Vanadis NIPT system - Flyer for Patients

Leaflet material that communicates the strengths of Vanadis NIPT.

Flyer
Flyer
Vanadis NIPT system - Flyer for Providers

Leaflet that explains the technology behind the Vanadis NIPT system.